Navigation Links
Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research
Date:1/11/2010

SEATTLE, Jan. 11 /PRNewswire/ -- William Clark, co-founder of Baby Einstein, has filed an open-records complaint in Washington state court (King County) asking a judge to order the University of Washington to release records relating to two studies that examined the effects of television viewing on young children.

Clark said he has been pursuing release of the experimental methods, raw data and interpretative methods of the "Associations Between Media Viewing and Language Development in Children Under Age 2 Years" and "Early Television Exposure and Subsequent Attentional Problems in Children" studies for nearly three years. The University has either denied his requests or failed to be fully responsive.

"All we're asking for is the basis for what the University has represented to be groundbreaking research," Clark said. "Given that other research studies have not shown the same outcomes, we would like the raw data and analytical methods from the Washington studies so we can audit their methodology, and perhaps duplicate the studies, to see if the outcomes are the same."

The studies were widely publicized when the researchers concluded television viewing by babies or younger children could be harmful. Baby Einstein and other brands of baby videos were named in the "Associations" article.

Clark believes parents should be discriminating about the quality of media they allow their children to watch, and how that media is used. He cited Baby Mozart, Baby Shakespeare and Baby Van Gogh as examples of age-appropriate content that exposes babies and parents to classical music, poetry and Impressionist art in a positive, engaging way.

Clark is not seeking any monetary gain. The Court may award recovery of legal fees and impose a penalty on the University of Washington. In the event a penalty is awarded, Clark will donate the proceeds to breast cancer research.

Clark submitted his first public records request for the "Associations" study in August 2007, after the University of Washington heavily publicized the research results. The University refused the request in November 2007, claiming the disclosure of the records would cause competitive harm to its researchers and thus would constitute "public harm." Clark subsequently asked the National Institute of Health (NIH), National Science Foundation (NSF) and The Journal of Pediatrics to request the University share the study's records.

In July 2009, Clark requested records for the 2004 "Early Television" study, and separately resubmitted his request for the 2007 "Associations" study. Four months later, in November

2009, Clark received two letters of "final response." The first letter stated no University records for the 2004 "Early Television" study could be found. The second letter was accompanied by an incomplete data set that cannot be used to re-analyze the 2007 "Associations" study, a copy of the study's questionnaire, and nothing more.

"If the research results are valid, the University of Washington should have welcomed timely re-analysis of its work," added Clark. "While they are being cited as 'evidence,' the University of Washington has not shared records or any documents that substantiate their claims with anyone interested in re-analyzing the studies."

Baby Einstein was founded in 1996 by Clark and his wife, Julie Aigner Clark. They sold the company to Disney in 2001, and have no financial stake in Baby Einstein or sale of its products. Clark has said his primary motivation in filing the lawsuit is to protect the legacy he and his wife have created.

Copy of the complaint:

www.aignerclark.com/newsroom


    William Clark is represented by:
    --------------------------------
    Rachel Matteo-Boehm                       Greg Overstreet
    Holme, Roberts & Owen LLP                 Allied Law Group
    415-268-1996 office                       360-753-7510 office
    rachel.matteo-boehm@hro.com               greg@alliedlawgroup.com

Data-sharing guidelines for the University of Washington, NIH and NSF:

SOURCE Aigner Clark Creative

RELATED LINKS
http://www.aignerclark.com/newsroom

'/>"/>

SOURCE Aigner Clark Creative
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Function Drinks President & Co-Founder, Dr. Alex Hughes, Joins the Faculty of Cornells Hospital for Special Surgery
2. Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal
3. Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia
4. Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June
5. Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenners New Face
6. Entrepreneurs Organization Hosts Pharmacy King Ralph Hoagland, Co-Founder of CVS
7. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
8. FamilyLife Co-Founder and Author Dr. Dennis Rainey Challenges Metroplex Couples to Celebrate Healthy Marriages this Valentines Day
9. Posit Science Co-Founder and Brain Plasticity Pioneer, Michael Merzenich, Speaks at Science Conference in the Netherlands
10. VisEn Co-Founder Named Radiologic Societys Outstanding Researcher of the Year
11. The Chopra Center Co-founders Will Teach a Beginning Course in Meditation and Mind-body Healing This August in Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two ... in excess of $835 million in resolved debt for its clients. , Credit card ... of the categories of debt settled by the company. With more than a decade ...
(Date:9/19/2017)... ... September 19, 2017 , ... Arizona-based ... as the President of its HealthBI division. McFarland will grow the organization’s ... , “Scott is a utility player who balances his day as a ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a new ... we’re born, Nature gives us a full supply of melanin – in the back ... this natural glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown ...
(Date:9/19/2017)... ... September 19, 2017 , ... Presenting its annual ... (SPBA) hosted “Expanding Your Success” with an educational emphasis. , The three-day ... best practices for third party administrators (TPAs) related to health plan management and ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/29/2017)... 29, 2017 In a move that promises ... compliance for veterinary practices of all sizes, Cubex LLC ... that makes TITAN,s expertise in physical security, drug diversion ... clients nationally. ... controlled substances is at risk today," said TITAN founder ...
Breaking Medicine Technology: